Botanical species · safety record

Achillea abrotanoides

The EFSA Compendium of Botanicals holds 17 constituent measurements for Achillea abrotanoides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Achillea abrotanoides (Vis.)Vis.

17Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • 1,8-cineole4
  • Beta-thujone4
  • (-)-camphor3
  • Alpha-thujone3
  • Guaianolides1
  • Myrcene1
  • Pinocarvone1

Plant parts

  • Aerial part of plants14
  • Leaves3

Preparations

  • Essential oil16
  • Solvent extraction1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
(-)-camphorLeavesEssential oil14.2 PercentGC-MSResolve DOI
(-)-camphorAerial part of plantsEssential oil≤ 14.2 PercentGC-MSResolve DOI
(-)-camphorAerial part of plantsEssential oil≥ 1.26 PercentGC-MSResolve DOI
1,8-cineoleAerial part of plantsEssential oil≥ 8.47 PercentGC-MSResolve DOI
1,8-cineoleLeavesEssential oil18.5 PercentGC-MSResolve DOI
1,8-cineoleAerial part of plantsEssential oil11.3 PercentGC-MSResolve DOI
1,8-cineoleAerial part of plantsEssential oil≤ 18.5 PercentGC-MSResolve DOI
Alpha-thujoneAerial part of plantsEssential oil2.9 PercentGC-MSResolve DOI
Alpha-thujoneAerial part of plantsEssential oil≥ 0.3 PercentGC-MSResolve DOI
Alpha-thujoneAerial part of plantsEssential oil≤ 35.4 PercentGC-MSResolve DOI
Beta-thujoneAerial part of plantsEssential oil≤ 10.2 PercentGC-MSResolve DOI
Beta-thujoneLeavesEssential oil10.2 PercentGC-MSResolve DOI
Beta-thujoneAerial part of plantsEssential oil16.8 PercentGC-MSResolve DOI
Beta-thujoneAerial part of plantsEssential oil≥ 3 PercentGC-MSResolve DOI
GuaianolidesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
MyrceneAerial part of plantsEssential oil3.2 PercentGC-MSResolve DOI
PinocarvoneAerial part of plantsEssential oil15.6 PercentGC-MSResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hanlidou, E., Kokkini, S., Kokkalou, E. Volatile constituents of Achillea abrotanoides in relation to their infrageneric variation. Biochemical systematics and ecology, 1992, vol. 20, no. 1, p. 33-40. DOI
  2. Bicchi, C., Frattini, C., Cantamessa, L., Poggio, L. On the composition of Achillea abrotanoides (Vis.) Vis. essential oil. Flavour and fragrance journal, 1988, vol. 3, no. 3, p. 101-104. DOI
  3. Chalchat, J.-C., Petrovic, S.D., Maksimovic, Z.A., Gorunovic, M.S. Aromatic plants of yugoslavia. III. Chemical composition of essential oils of achillea abrotanoides (Vis.) Vis., A. Clypeolata Sibth. & Sm., A. depressa Janka and A. Stricta Schleicher et Koch. Journal of essential oil research, 2005, vol. 17, no. 5, p. 549-552. DOI
  4. Stefanovic, M., Djermanovic, V., Gorunvic, M., Djermanovic, M., Macura, S., Milosavljevic, S. Sesquiterpene lactones from Achillea abrotanoides. Phytochemistry, 1989, vol. 28, no. 6, p. 1765-1767. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue